CorVista Health is Hiring Chief of Staff

This role is an integral part of the growth and success of a dynamic, fast paced startup at the cusp of commercialization.  We seek a strong Chief of Staff who will work closely with the CEO on execution of all projects associated with the success of the company, from administrative to HR support, stakeholder communications, and beyond.  We seek a professional with a “can do” attitude who is detail-oriented, resourceful, organized and holds a high degree of professionalism.



  • Provide high-level administrative support to the CEO and leadership team who move fast and are building a rapidly growing Health technology company
  • Improve current processes and coordinate organizational procedures for optimized efficiency and productivity
  • Project manager on new facility in Washington, DC
  • Maintains executive appointment schedule by planning and scheduling meetings, conferences, and travel
  • Manages and maintains executive calendar
  • Tracks and prioritizes projects perform supporting research and effectively communicates within the organization
  • Execute special or continuous research and data analysis. Analyzes problems, determines approach, compiles and analyzes data, and prepares reports / recommendations for action by a management team.
  • Assist in HR-related activities; work with our consultant in establishing formal processes and procedures
  • Manage and gathering of confidential onboarding documentation checklists/procedures
  • Manage confidential termination checklists/procedures
  • Assist/lead board-related communications/activities, board meetings
  • Assist/administer shareholder communications program, shareholder meetings, etc.
  • Maintain equity documents in CARTA system
  • Assist/administer public relations/corporate communications activities
  • Assist/administer communications program with strategics, bankers, etc.
  • Assist/administer contracts management and some negotiations
  • Provide support in JLabs office



  • Demonstrated competency in project management
  • Entrepreneurial and willingness to “roll up sleeves”
  • Be extremely computer savvy
  • Have excellent written and verbal communication skills
  • Be flexible and take initiative on projects
  • Have outgoing and creative personality
  • Be able to multi-task and work on several projects at once
  • Have a desire to get involved and understand the needs of a growing business
  • Have basic experience with social media
  • Possesses excellent communication skills; both written and verbal
  • Problem Solver – Quantitative Aptitude, Logical Reasoning
  • Experience creating systems, processes and procedures- Abstract Reasoning
  • Detail-oriented, organized, and self-starting
  • Bachelor’s degree required
  • Commutable distance to Washington DC

To Apply:

Recent News


Bio-plastics startup wins Lighthouse Labs pitch contest

Charlottsville, VA (Virginia Business) – While pitching to the sharks, entrepreneur Alec Brewer told them, “I do have white powder in my pocket,” before quickly clarifying that it wasn’t an illicit substance: “It’s PHB! It’s PHB!” The co-founder and CEO of Charlottesville-based biodegradable plastics manufacturer Ourobio, Brewer explained that his company makes PHB, or polyhydroxybutyrate,


USA FDA Grants Fast Track Designation to ReAlta Life Sciences’ Lead Compound RLS-0071

ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing the power of the immune system to address life threatening diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to RLS-0071 for the treatment of hypoxic ischemic encephalopathy (HIE). RLS-0071 is the Company’s lead dual


Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence

New patent covers the use of the full genetic panel measuring all five genetic biomarkers CHARLOTTESVILLE, Va., — Adial Pharmaceuticals, Inc. (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced patent number 11,351,154 was issued on June 7, 2022, by